Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Qingsong Zhu


Insilico Medicine has hired Qingsong Zhu to serve as its chief operating officer. In this role, he will be in charge of the company's operations and drug discovery research initiatives.

Prior to joining the company, Zhu spent seven years as a postdoctoral research fellow in the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University and has also worked as an independent consultant to apply next-generation sequencing to develop diagnostics and personalized medicine. Zhu holds a bachelors degree in biology from the Beijing Forestry University in Beijing and doctorate in biochemistry from Kansas State University.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.